Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2006 by E-DA Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

E-DA Hospital

ClinicalTrials.gov Identifier:

NCT00395616

First received: November 2, 2006

Last updated: NA

Last verified: November 2006

History: No changes posted

Tracking Information

First Received Date ^ICMJE

November 2, 2006

Last Updated Date

November 2, 2006

Start Date ^ICMJE

November 2006

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

WHOQOL-BREF
visual analogue scale for pain
grip strength

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

Official Title ^ICMJE

Not Provided

Brief Summary

Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Condition ^ICMJE

Type A Botulinum Toxin
Tennis Elbow

Intervention ^ICMJE

Drug: Botox (drug)

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Pain at the lateral epicondyle of the elbow
Tenderness at the lateral epicondyle of the elbow
Pain on resisted extension of the wrist

Exclusion Criteria:

Local injection of steroid within 3 months
Previous elbow trauma or operations
Pregnancy
Systemic neuromuscular disorders such as myasthenia gravis

Gender

Both

Ages

20 Years to 80 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Yu-Ching Lin, MD

886-7-6150011 ext 2367

yuchinglin2003@yahoo.com.tw

Location Countries ^ICMJE

Taiwan

Administrative Information

NCT Number ^ICMJE

NCT00395616

Other Study ID Numbers ^ICMJE

e120537192

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

E-DA Hospital

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Chair:

Yu-Ching Lin, MD

E-Dah Hospital, Kaohsiung, Taiwan

Information Provided By

E-DA Hospital

Verification Date

November 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top